Azitra, Inc. (NYSEAMERICAN:AZTR) Sees Significant Increase in Short Interest

Azitra, Inc. (NYSEAMERICAN:AZTR) was the recipient of a large growth in short interest during the month of March. As of March 13th, there was short interest totaling 343,444 shares, a growth of 177.1% from the February 26th total of 123,961 shares. Approximately 2.1% of the shares of the stock are sold short. Based on an average daily volume of 1,772,449 shares, the days-to-cover ratio is currently 0.2 days.

Azitra Stock Performance

Shares of NYSEAMERICAN AZTR traded up $0.00 during trading hours on Friday, reaching $0.24. 4,835,688 shares of the stock traded hands, compared to its average volume of 13,077,348. The company’s 50-day simple moving average is $0.22 and its two-hundred day simple moving average is $0.40. Azitra has a 52-week low of $0.10 and a 52-week high of $2.66.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.